GO
Loading...

Enter multiple symbols separated by commas

GlaxoSmithKline PLC

More

  • US firms in China: We feel less welcome here Tuesday, 10 Feb 2015 | 8:00 PM ET

    American businesses feel increasingly less welcome in China, according to a new survey, with rising protectionism in the mainland a top concern.

  • Feb 10- The Canadian government will require pharmaceutical companies to post public notices when drugs are not available or face fines, Health Minister Rona Ambrose said on Tuesday. The website, www.drugshortages.ca, lists more than 200 recent shortages of drugs made by companies including Valeant Pharmaceuticals Inc, GlaxoSmithKline PLC and Pfizer...

  • WASHINGTON, Feb 10- For the first time in 20 years, patients suffering from the eye disease glaucoma may soon have new treatments as several young companies look to shake up the $5.6 billion global market. No new class of medicine has been introduced since Pfizer Inc's N> Xalatan, known generically as latanoprost, in 1996.. The newcomers aim to disrupt...

  • Early movers: TWTR, MSG, EBAY, GPRO & more Friday, 6 Feb 2015 | 8:00 AM ET

    Some of the names on the move ahead of the open.

  • Lightning Round: Why you should buy Box again Thursday, 5 Feb 2015 | 7:48 PM ET
    Mad Money Lightning Round

    Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Wednesday's midday movers: Comcast, Apple & more Wednesday, 4 Feb 2015 | 12:16 PM ET
    Traders on the floor of the New York Stock Exchange.

    Take a look at some of Wednesday's midday movers:

  • Europe shares close mixed; LVMH, Greek banks soar Wednesday, 4 Feb 2015 | 11:40 AM ET

    European shares closed mixed on Wednesday, as investors reacted to earnings and hopes that the Greek debt dispute will be resolved.

  • GSK sales falls; firm upbeat on respiratory unit Wednesday, 4 Feb 2015 | 8:45 AM ET

    Shares of GlaxoSmithKline jumped on Wednesday, despite the company posting a 3 percent fall in full-year revenue.

  • *Novartis deal on track to close in first half 2015. GSK is also banking on an asset swap with Novartis to help revive its fortunes, and looking to unlock value by floating its HIV unit ViiV Healthcare. GSK is buying vaccines, selling cancer drugs and forming a consumer health joint venture with Novartis in a $20- billion transaction designed to ensure more stable...

  • LONDON, Feb 4- GlaxoSmithKline said on Wednesday it expected to start to regain market share in respiratory medicine after weak demand for lung drug Advair again hurt fourth-quarter sales, capping a rough year for Britain's top drugmaker. GSK is also banking on an asset swap with Novartis to help revive its fortunes, and looking to unlock value by floating its...

  • Stocks close up sharply, boosted by Greece and oil Monday, 2 Feb 2015 | 4:00 PM ET
    Traders work on the floor of the New York Stock Exchange.

    U.S. stocks closed sharply higher on encouraging news from the Eurozone and stronger oil prices.

  • MONROVIA, Feb 2- Liberia began a trial of experimental Ebola vaccines on Monday, involving thousands of volunteers as part of an effort to slow the spread of the deadly haemorrhagic fever and prevent future outbreaks. The epidemic has killed more than 8,900 people in West Africa since it began more than a year ago, overwhelming weak healthcare systems in Guinea,...

  • MONROVIA, Feb 2- Liberia began a trial of experimental Ebola vaccines on Monday, involving thousands of volunteers as part of an effort to slow the spread of the deadly haemorrhagic fever and prevent future outbreaks. The epidemic has killed more than 8,800 people in West Africa since it began more than a year ago, overwhelming weak healthcare systems in Guinea,...

  • LONDON, Feb 1- As West Africa's devastating Ebola outbreak begins to dwindle, scientists are looking beyond the endgame at the kind of next-generation vaccines needed for a vital stockpile to hit another epidemic hard and fast. Determined not to lose scientific momentum that could make the world's first effective Ebola interventions a reality, researchers...

  • NEW YORK, Jan 29- When Marty Weinstein decided to quit smoking, he took a friend's advice and tried electronic cigarettes rather than government-approved nicotine replacement products. E-cigarette makers in the United States are barred from explicitly marketing the products as smoking cessation devices, but have found ways to appeal legally to smokers who...

  • BERLIN, Jan 27- International donors pledged $7.5 billion on Tuesday to immunize 300 million children in poor countries against deadly diseases such as diarrhea and pneumonia. At a Global Alliance for Vaccines and Immunization conference in Berlin, Microsoft founder Bill Gates and the British government topped the donations list at $1.55 billion and $1.5...

  • Novartis flags faster sales, profit growth for 2015 Tuesday, 27 Jan 2015 | 2:48 AM ET
    Joe Jimenez, CEO of Novartis, at 2015 WEF in Davos, Switzerland.

    Novartis forecast sales and profits to grow at a faster pace this year driven by recent drug successes and its portfolio overhaul.

  • *Core EPS $1.21 vs $1.18 forecast in Reuters poll. ZURICH, Jan 27- Swiss drugmaker Novartis forecast sales and profits to grow at a faster pace this year as recent drug successes and its portfolio overhaul help it weather the impact of generic competition. Novartis unveiled a transformative series of deals last year which will see it focus on a smaller number of...

  • LONDON, Jan 26- Pfizer is to cut the price of its pneumococcal vaccine Prevenar 13 by 6 percent to $3.10 per dose in poor countries as part of a commitment to the GAVI global vaccines alliance, the U.S. drugmaker said on Monday. Pfizer's move comes as GAVI holds a major funding conference in Berlin at which it hopes to raise $7.5 billion from donors to pay for increased...

  • LONDON, Jan 23- The first batch of GlaxoSmithKline's experimental Ebola vaccine has been dispatched to West Africa and is expected to arrive in Liberia later on Friday, the British drugmaker said. The World Health Organization said on Thursday the Ebola outbreak in West Africa, the worst in history, appears to be waning but cautioned against complacency.